Antiplatelet therapy following transcatheter aortic valve implantation
- Hassell, Mariëlla E. C. J
- Hildick Smith, David
- Durand, Eric
- Kikkert, Wouter J
- Wiegerinck, Esther M. A
- Ussia, Gian Paolo
- Sharma, Sumeet
- Baan, Jan
- Eltchaninoff, Hélène
- Rubino, Paolo
- Barbanti, Marco
- Tamburino, Corrado
- Poliacikova, Petra
- Blanchard, Didier
- Piek, Jan J
- Delewi, Ronak
- STABILE, EUGENIO
Publication date
January 2015
DOI Publisher
BMJ ISSN
1355-6037 Citation count (estimate)
29Abstract
There is limited evidence to support decision making on antiplatelet therapy following transcatheter aortic valve implantation (TAVI). Our aim was to assess the efficacy and safety of aspirin-only (ASA) versus dual antiplatelet therapy (DAPT) following TAVI
Add to ORKG